♟️ Monday 5 October 2026 Mon, 5 Oct 2026

Moab Minerals has resumed trading after lodging an annual report that shows a smaller loss but a stark liquidity warning. The uranium explorer says it needs fresh capital, creditor support and lower costs to continue operating normally.

Neurotech International has moved NTI164 into a registration-enabling Phase III autism trial, but its annual report carries a material going-concern warning. The company says post-year-end debt and equity funding should support the program through topline data, subject to execution and completion.

Clime Capital delivered a sharply stronger FY26 result, with after-tax profit rising to $10.3 million and dividends maintained. But KPMG qualified its audit after failing to obtain sufficient evidence for $36.2 million of unlisted unit trust valuations and related income and fees.

Surefire Resources is seeking up to A$2.61 million through a share placement, alongside an option entitlement offer for existing eligible shareholders. The raise could materially expand the company’s securities on issue, with the second tranche and related options requiring shareholder approval.

OD6 Metals has secured A$6.92 million from institutional and sophisticated investors to advance drilling, bulk sampling and resource definition at its Quinn Fluorspar Project in Nevada. The funding also sets up a proposed rebrand to Adaven, but brings dilution and a substantial package of shareholder approvals.

Optiscan Imaging has lodged a US FDA 510(k) application for InVue, its precision surgery device designed to provide cellular-level imaging during operations. The submission moves the technology into formal regulatory review, but clearance and commercialisation remain uncertain.

Aspen Group delivered a stronger-than-expected first quarter, with net rental income up 16% and realised development profit nearly doubling to $7.9 million. The company maintained its FY27 targets, while warning that weaker economic conditions could disrupt development settlements.

PDI Gold has paired a strong September quarter with high-grade drilling beneath its Kiniéro pits, strengthening the case for further resource growth at Guinea’s producing gold operation. The results remain exploration-stage, but the company is preparing a 140,000-metre campaign for 2027.

Osmond Resources has secured the maximum €250,000 provisional grant in the first round of Spain’s national mineral exploration program, while preparing to start a 13-hole campaign at its Orión project. The company has also issued 85 million shares to retain its 80% interest in the project-owning vehicle.

Aurora Labs has appointed Andrew Garth as chief executive, moving former CEO Rebekah Letheby into a newly focused chief operating role. The reshuffle is intended to separate commercial strategy from technical execution as the company pursues scaled manufacturing and defence opportunities.

Zenith Minerals has rejected an unsolicited $5 million capital-raising proposal from Aurenne, saying it is incomplete, difficult to implement and offers shareholders no direct consideration. The board has kept its recommendation of Forrestania Resources’ takeover offer unchanged.

CSL has secured an exclusive agreement to co-develop and co-promote Alentis Therapeutics’ investigational drug lixudebart, committing US$355 million upfront and funding a multi-trial development programme. The antibody remains unapproved, with its commercial potential dependent on results from ongoing and planned clinical studies.

Brightstar Resources has delivered broad and high-grade gold intercepts from final infill drilling at Bull Oak, including 167 metres at 2.07g/t gold and a 0.5-metre zone grading 265g/t. The results are intended to support an updated Mineral Resource and the Sandstone project’s pre-feasibility study, although neither has yet been released.

HealthCo Healthcare and Wellness REIT has signed binding agreements for new leases covering its remaining 10 Healthscope hospitals, subject to final approvals. The resolution allows HCW to reinstate quarterly distributions while reducing its largest tenant concentration from 57% to 31%.

Brazilian Critical Minerals has signed binding agreements to acquire 90% of a Brazilian magnesium sulphate producer, aiming to secure a key input for its Ema rare earth project. The strategy offers greater supply-chain control, but the plant requires restructuring and carries estimated legacy liabilities of R$15.3 million.

BMC Minerals has intersected significant silver, zinc, gold, copper and lead mineralisation in all nine reported holes at the Rhyolite Peak prospect, 1.2km from its proposed ABM mine. Six further assays are pending as the company moves toward completing its 20,000m 2026 drilling program.

Rox Resources has reached financial close on A$350 million of debt facilities for the Youanmi Gold Mine, removing the conditions that had stood between the funding package and construction spending. The company has initially drawn A$90.2 million in project debt and used a further A$4 million bank guarantee facility allocation.